Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats.
BACKGROUND
Azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in rats shares many phenotypical similarities with human sporadic colon cancer and is a reliable model for identifying chemopreventive agents. Genetic mutations relevant to human colon cancer have been described in this model, but comprehensive gene expression and genomic analysis have not been reported so far. Therefore, we applied genome-wide technologies to study variations in gene expression and genomic alterations in DMH-induced colon cancer in F344 rats.


METHODS
For gene expression analysis, 9 tumours (TUM) and their paired normal mucosa (NM) were hybridized on 4 x 44K Whole rat arrays (Agilent) and selected genes were validated by semi-quantitative RT-PCR. Functional analysis on microarray data was performed by GenMAPP/MappFinder analysis. Array-comparative genomic hybridization (a-CGH) was performed on 10 paired TUM-NM samples hybridized on Rat genome arrays 2 x 105K (Agilent) and the results were analyzed by CGH Analytics (Agilent).


RESULTS
Microarray gene expression analysis showed that Defcr4, Igfbp5, Mmp7, Nos2, S100A8 and S100A9 were among the most up-regulated genes in tumours (Fold Change (FC) compared with NM: 183, 48, 39, 38, 36 and 32, respectively), while Slc26a3, Mptx, Retlna and Muc2 were strongly down-regulated (FC: -500; -376, -167, -79, respectively). Functional analysis showed that pathways controlling cell cycle, protein synthesis, matrix metalloproteinases, TNFalpha/NFkB, and inflammatory responses were up-regulated in tumours, while Krebs cycle, the electron transport chain, and fatty acid beta oxidation were down-regulated. a-CGH analysis showed that four TUM out of ten had one or two chromosomal aberrations. Importantly, one sample showed a deletion on chromosome 18 including Apc.


CONCLUSIONS
The results showed complex gene expression alterations in adenocarcinomas encompassing many altered pathways. While a-CGH analysis showed a low degree of genomic imbalance, it is interesting to note that one of the alterations concerned Apc, a key gene in colorectal carcinogenesis. The fact that many of the molecular alterations described in this study are documented in human colon tumours confirms the relevance of DMH-induced cancers as a powerful tool for the study of colon carcinogenesis and chemoprevention.
Femia
Angelo Pietro
AP
Department of Pharmacology, University of Florence, 6 Viale Pieraccini, 50139 Florence, Italy.
Luceri
Cristina
C
Toti
Simona
S
Giannini
Augusto
A
Dolara
Piero
P
Caderni
Giovanna
G
D019813:1,2-Dimethylhydrazine; D000230:Adenocarcinoma / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D055028:Comparative Genomic Hybridization; D020869:Gene Expression Profiling / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic; D053263:Gene Regulatory Networks; D007150:Immunohistochemistry; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D051381:Rats; D011916:Rats, Inbred F344; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction
D019813:1,2-Dimethylhydrazine
Cancer Res. 2004 Sep 15;64(18):6394-401
15374946
Cancer Lett. 2009 Apr 18;276(2):125-35
18790562
Cancer Res. 2006 Oct 15;66(20):9837-44
17047044
Genome Biol. 2007;8(7):R131
17615082
Cell. 2008 Jul 25;134(2):215-30
18662538
Carcinogenesis. 2000 Sep;21(9):1753-6
10964108
J Nutr. 2002 Jun;132(6):1376-9
12042461
Annu Rev Nutr. 2004;24:151-72
15189117
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1688-94
19505900
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18199-204
17989230
FASEB J. 2003 Jul;17(10):1277-85
12832292
Carcinogenesis. 2008 May;29(5):890-4
18453540
Histol Histopathol. 2007 Mar;22(3):251-60
17163399
Oncol Rep. 2006 Dec;16(6):1225-30
17089042
Carcinogenesis. 2001 Jul;22(7):1035-42
11408346
Br J Nutr. 2009 Dec;102(11):1620-8
19622193
J Natl Cancer Inst. 1993 Apr 21;85(8):667-9
8385712
Oncogene. 2004 May 6;23(21):3813-21
15021908
J Surg Oncol. 1998 Jun;68(2):92-9
9624037
Biochem J. 2006 Apr 1;395(1):1-19
16526944
Nat Genet. 1996 Nov;14(3):316-9
8896562
Planta Med. 2008 Oct;74(13):1602-7
18604780
Int J Cancer. 2007 Jun 1;120(11):2301-5
17294441
Cancer Res. 1998 Jan 15;58(2):334-41
9443414
Annu Rev Physiol. 2009;71:241-60
18808327
Curr Opin Oncol. 2005 Jan;17(1):49-54
15608513
Cancer Res. 2005 Aug 15;65(16):7363-9
16103088
Cancer Res. 1995 Oct 15;55(20):4722-8
7553655
Cancer Res. 2009 Jul 15;69(14):5768-75
19584276
Carcinogenesis. 2002 Nov;23(11):1953-60
12419846
Carcinogenesis. 2000 Jul;21(7):1319-27
10874009
Nature. 2007 Oct 25;449(7165):1003-7
17934449
Carcinogenesis. 2004 Aug;25(8):1495-505
15059925
Int J Cancer. 1997 Jul 3;72(1):1-22
9212216
Nature. 1992 Sep 17;359(6392):235-7
1528264
Electrophoresis. 1999 Apr-May;20(4-5):1047-54
10344284
Int J Cancer. 2009 Aug 1;125(3):541-7
19431205
Biochem Pharmacol. 2006 Nov 30;72(11):1622-31
16846592
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4166-70
7683425
Free Radic Biol Med. 2007 Aug 1;43(3):415-22
17602957
Int J Cancer. 2008 Jan 1;122(1):117-23
17847023
Cancer Res. 2004 Jul 15;64(14):4687-92
15256431
Nat Rev Drug Discov. 2006 Dec;5(12):997-1014
17139285
Carcinogenesis. 2008 Nov;29(11):2106-11
18775916
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12098-102
16880406
Gastroenterology. 2007 Feb;132(2):628-32
17320548
J Immunol. 2009 Feb 15;182(4):2357-63
19201890
Eur J Cancer. 2005 Sep;41(13):1911-22
16084718
Cancer Lett. 2006 Aug 8;239(2):246-53
16216410
Cancer Biol Ther. 2006 Apr;5(4):419-26
16575208
Biochim Biophys Acta. 2007 Jan;1775(1):103-37
17010523
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17
15000152
Nat Cell Biol. 2005 Apr;7(4):381-6
15778706
Cancer Res. 2005 Jan 1;65(1):166-76
15665292